Latest News & Features
article
The ‘formidable’ three bring 52 years’ experience from Fish & Richardson collectively | ‘Extensive’ patent trial background includes branded Hatch-Waxman litigation. 6 June 2023
article
Case involved the alleged monopolisation of an opioid addiction treatment |
More than 40 attorneys general had filed complaints against the pharma company. 6 June 2023
Big Pharma
Big pharma company picks pan-European venue for next leg of global dispute | IT issues potentially behind new court's low revocation count | Nearly half a million opt-outs registered. 6 June 2023
Big Pharma
Ex-scientist faces lawsuit for allegedly downloading thousands of files before leaving for a rival | Abbott seeks damages for ‘flagrant misconduct’ brought to its attention by successive employer. 1 June 2023
article
A project decades in the making, the Unified Patent Court and Unitary Patent promise to change the European IP landscape, writes Marisa Woutersen. 1 June 2023
Big Pharma
A US biotech is accusing the pair of infringing several of its “foundational” lipid particle patents | Pfizer and BioNTech accused plaintiff in earlier suit of antitrust in a dispute over one of the patents at issue. 30 May 2023
article
Court outlines submission method in the event of CMS failure | Hard-copy format requirements include USB stick and delivery to Luxembourg | Guidelines have “made people nervous” say lawyers | Full details on how to submit. 30 May 2023
Medtech
Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents. 25 May 2023
Big Pharma
Amgen can market biosimilar version of Stelara from January 2025 | J&J had alleged infringement of two Stelara patents. 25 May 2023
Big Pharma
Two subsidiaries of the French pharma giant allege ‘wilful’ patent infringement by the Swiss-American pharma firm | Novartis ‘hid’ information in a previous lawsuit relating to spinal muscular atrophy drug used to treat young children. 23 May 2023